RasGRP1 is a potential biomarker for stratifying anti-EGFR therapy response in colorectal cancer
- Citation:
- JCI Insight vol 4 (15)
- Year:
- 2019
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Secondary-not-in-original
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- Received
- Note:
- Methodological:
- No
- Biospecimen:
- Yes
- SDC:
- No
- Book Volume:
- 8
- Parents:
- None
- Children:
- None
- Pharmas:
- Grants:
- U10CA180821, U10CA180882, U24CA196171, 1P01AI091580-01, 104-2917-I-006-002, 1R01DK115728
- Corr. Author:
- Authors:
- Oghenekevwe M. Gbenedio Caroline Bonnans Delphine Grun Chih-Yang Wang Ace J. Hatch Michelle R. Mahoney David Barras Mary Matli Yi Miao K. Christopher Garcia Sabine Tejpar Mauro Delorenzi Alan P. Venook Andrew B. Nixon Robert S. Warren Jeroen P. Roose Philippe Depeille
- Networks:
- CA136, CA824, LAPS-MA036, LAPS-MN026, LAPS-NC010
- Study
- CALGB-80203
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords:
- Gastroenterology, Therapeutics, Colorectal cancer, Drug therapy, Signal transduction